Seth van Voorhees - 25 Nov 2022 Form 4 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Reporting relationship: CHIEF FINANCIAL OFFICER
Issuer ticker: NRXP
Reported as of: 25 Nov 2022
Net transaction value: +$18,215
SEC form: 4
Accepted by SEC: 28 Nov 2022, 06:42:26 UTC
Prior SEC filing: 29 Jun 2022
Next SEC filing: 19 Dec 2022
Source filing: View source filing
Reporting owner signature: /s/ Seth Van Voorhees

Key filing fact

Seth van Voorhees filed Form 4 for NRX Pharmaceuticals, Inc. (NRXP) on 28 Nov 2022.

Key facts

This page summarizes Seth van Voorhees's Form 4 filing for NRX Pharmaceuticals, Inc. (NRXP).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 28 Nov 2022, 06:42.

Change

Previous filing in this sequence was filed on 29 Jun 2022.
Current net transaction value: +$18,215.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

This filing has been restated. Open the amended filing.

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NRXP transaction

Common Stock, par value $0.001 per share

Purchase

Transaction value: $9,762
Shares: +8,716
Change %
Price: $1.12
Shares after: 8,716
Date: 25 Nov 2022
Ownership: Shares purchased though 401(k) plan

NRXP transaction

Common Stock, par value $0.001 per share

Purchase

Transaction value: $660
Shares: +600
Change %: +6.9%
Price: $1.10
Shares after: 9,316
Date: 25 Nov 2022
Ownership: Shares purchased though 401(k) plan

NRXP transaction

Common Stock, par value $0.001 per share

Purchase

Transaction value: $7,793
Shares: +7,021
Change %: +75%
Price: $1.11
Shares after: 16,377
Date: 25 Nov 2022
Ownership: Shares purchased though 401(k) plan

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .